Severe acute fibrinous and organizing pneumonia (AFOP) causing ventilatory failure: Successful treatment with mycophenolate mofetil and corticosteroids

Respiratory Medicine

Volumn 103, Issue 11, 2009, Pages 1764-1767

  Bhatti, Sabha ^a   Hakeem, Abdul ^a   Torrealba, Jose ^b   McMahon, Joseph P ^c   Meyer, Keith C ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b University of Wisconsin Health   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Acute fibrinous and organizing pneumonia (AFOP)

Indexed keywords

AZITHROMYCIN; CORTICOSTEROID; LEVOFLOXACIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ACUTE FIBRINOUS AND ORGANIZING PNEUMONIA; ACUTE FIBRINOUS ORGANIZING PNEUMONIA; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BRONCHOSCOPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG DOSE INCREASE; HUMAN; LUNG BIOPSY; LUNG INJURY; LUNG LAVAGE; MALE; PRIORITY JOURNAL;

ADRENAL CORTEX HORMONES; CRYPTOGENIC ORGANIZING PNEUMONIA; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MYCOPHENOLIC ACID; PULMONARY FIBROSIS; TREATMENT OUTCOME;

EID: 70349484850     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.07.009     Document Type: Article

References (6)

1. Beasley M.B., Franks T.J., Galvin J.R., Gochuico B., and Travis W.D. Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med 126 9 (2002 Sep) 1064-1070
2. Damas C., Morais A., Moura C.S., and Marques A. Acute fibrinous and organizing pneumonia. Rev Port Pneumol 12 5 (2006 Sep-Oct) 615-620
3. Zamora A.C., Wolters P.J., Collard H.R., Connolly M.K., Elicker B.M., Webb W.R., King Jr. T.E., and Golden J.A. Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease. Respir Med 102 1 (2008 Jan) 150-155
4. Vanthuyne M., Blockmans D., Westhovens R., Roufosse F., Cogan E., Coche E., Nzeusseu Toukap A., and Depresseux G. Houssiau FAA pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis. Clin Exp Rheumatol 25 2 (2007 Mar-Apr) 287-292
5. Swigris J.J., Olson A.L., Fischer A., Lynch D.A., Cosgrove G.P., Frankel S.K., Meehan R.T., and Brown K.K. Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease. Chest 130 1 (2006 Jul) 30-36
6. Ginzler E.M., Dooley M.A., Aranow C., Kim M.Y., Buyon J., Merrill J.T., Petri M., Gilkeson G.S., Wallace D.J., Weisman M.H., and Appel G.B. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 353 21 (2005 Nov 24) 2219-2228